Abstract
Meeting abstracts Recent studies linking immune signatures in cancer with prognosis have provided unequivocal proof of the essential role of the immune system in tumor pathophysiology. They have also initiated a quest for immune biomarkers that could serve as intermediate endpoints of response to
Highlights
Recent studies linking immune signatures in cancer with prognosis have provided unequivocal proof of the essential role of the immune system in tumor pathophysiology
Fifty breast cancer (BCa) patients were enrolled with written informed consent
Significant correlations among cytokines/chemokines or mi-RNAs in sera were detected among patients but not in healthy donors
Summary
Recent studies linking immune signatures in cancer with prognosis have provided unequivocal proof of the essential role of the immune system in tumor pathophysiology. They have initiated a quest for immune biomarkers that could serve as intermediate endpoints of response to therapy and outcome in cancer. In view of growing evidence for interplay between tumor and systemic circulation, it is critically important to define relationships between the tumor and the periphery in order to reveal novel prognostic and/or predictive biomarkers for cancer
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
